Dumont, James

Track

Insider profile

Performance

Overall performance
2.2
Performance over holding periods
2.2
30 days 90 days 120 days
Average return -1% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
4 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Dumont, James's trades of PharmaCorp Rx Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
266.17
Quantity 93,730 -41.7%
Value CA$4,735,347
Transaction date
Purchase
Price
496.60
Quantity 40,058 +41.5%
Value CA$1,675,779
Transaction date
Purchase
Price
14.17
Quantity 4,897
Value CA$4,950,043
Transaction date
Purchase
Price
0.42
Quantity 178,650 +71.5%
Value CA$75,033
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-15 2026-07-09
B Purchase
93,730 -41.7%
266.17
CA$4,735,347 		93,730 -41.7% 266.17 CA$4,735,347
2026-07-15 2026-07-09
B Purchase
40,058 +41.5%
496.60
CA$1,675,779 		40,058 +41.5% 496.60 CA$1,675,779
2025-11-14 2025-11-12
B Purchase
4,897
14.17
CA$4,950,043 		4,897 14.17 CA$4,950,043
2025-11-14 2025-11-12
B Purchase
178,650 +71.5%
0.42
CA$75,033 		178,650 +71.5% 0.42 CA$75,033